The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib
-
* Corresponding author: Allen S Yang allenyan@usc.edu
Journal of Hematology & Oncology 2009, 2:46 doi:10.1186/1756-8722-2-46
Accesses
- Last 30 days: 139 accesses
- Last 365 days: 1421 accesses
- All time: 3849 accesses